HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(5,6-dimethoxyindan-2-yl)dipropylamine

has 20-fold preference for D3 versus D2 dopamine receptors
Also Known As:
5,6-dimethoxy-2-(di-n-propylamino)indan; 5,6-dimethoxy-2-(dipropylamino)indan hydrochloride; PNU 99194A; PNU-99194A; U 99194; U 99194A; U-99194; U-99194A
Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ohno, Yukihiro: 2 articles (01/2022 - 04/2014)
2. Shimizu, Saki: 2 articles (01/2022 - 04/2014)
3. Iha, Higor A: 1 article (01/2022)
4. Kato, Masaki: 1 article (01/2022)
5. Kunisawa, Naofumi: 1 article (01/2022)
6. Andatsu, Saki: 1 article (04/2014)
7. Kizu, Tomoya: 1 article (04/2014)
8. Miyoshi, Satoshi: 1 article (04/2014)
9. Sato, Maho: 1 article (04/2014)
10. Sugiuchi, Tomone: 1 article (04/2014)

Related Diseases

1. Ocular Hypotension
2. Catalepsy
3. Vomiting
4. Tremor (Tremors)
5. Dystonia (Limb Dystonia)

Related Drugs and Biologics

1. 7-hydroxy-2-N,N-dipropylaminotetralin
2. Haloperidol (Haldol)
3. Raclopride
4. Quinpirole
5. Scopolamine (Hyoscine)
6. Nicotine
7. Dopamine (Intropin)
8. Apomorphine
9. Antiemetics
10. AD 6048

Related Therapies and Procedures

1. Sympathectomy (Sympathectomies)